US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Takeda Pharmaceutical Co Ltd

17.86

0.0000

Post-market: 17.860.00000.00%19:30 EDT

Volume:2.13M

Turnover:38.05M

Market Cap:56.84B

PE:-56.09

High:17.89

Open:17.85

Low:17.78

Close:17.86

52wk High:19.10

52wk Low:12.99

Shares:3.18B

Float Shares:3.09B

Volume Ratio:0.91

T/O Rate:0.07%

Dividend:0.63

Dividend Rate:3.55%

EPS(TTM):-0.3184

EPS(LYR):-0.3042

ROE:-2.26%

ROA:2.69%

PB:1.19

PE(LYR):-58.70

Loading ...

Overview Company News Filings

Takeda, Indonesian Government Launch Program to Build National Plasma Ecosystem

MT Newswires Live

Takeda, the Indoensian Government announce collaboration

Insilico Medicine Announces Strategic Collaboration with Takeda for AI-Driven Drug Discovery

Takeda, Insilico Strike AI Drug-discovery Deal Worth up to $600.0 Million

Alkermes Faces Risk on Orexin-Related Value From Upcoming Updates, BofA Says

MT Newswires Live

Takeda's First Female CEO Outlines Strategy for Growth Rebound and Major Product Launches

Takeda Pharmaceutical Appoints Julie Kim as Chief Executive

MT Newswires Live

Asian Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading

MT Newswires Live

Takeda Canada Says Zasocitinib Shows Superiority to Deucravacitinib in Phase 3 Psoriasis Study

MT Newswires Live

Takeda Canada reports ‘positive’ results from Phase 3 study of zasocitinib

Takeda’s High-Stakes Overhaul: CEO Transition and Major Restructuring Raise Execution and Profitability Risks

Takeda presents additional results from oveporexton studies at SLEEP 2026

Takeda Pharmaceutical's Psoriasis Treatment Beats Competitor in Trial

MT Newswires Live

Takeda announces results for Phase 3 study of TAK-279

Takeda's Application for ENTYVIO IV Accepted by FDA in Pediatric Ulcerative Colitis and Crohn's Disease

MT Newswires Live

FDA accepts Takeda’s application for intravenous Entyvio

Takeda’s TAK-360 Narcolepsy Trial Moves Forward, Expanding Its Specialty CNS Pipeline

Takeda swings to FY25 net loss of JPY 152.1 billion; FY25 revenue falls 1.7% to JPY 4.51 trillion

Takeda’s New Mezagitamab Trial Targets High-Risk Kidney Rejection, Bolstering Long-Term Pipeline Story

Takeda’s Real-World Maribavir Study in Argentina: What Investors Should Watch

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/TAK/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TAK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","market":"US","secType":"STK","nameCN":"Takeda Pharmaceutical Co Ltd","latestPrice":17.86,"timestamp":1790971200000,"preClose":17.86,"halted":0,"volume":2132769,"hourTrading":{"tag":"盘后","latestPrice":17.86,"preClose":17.86,"latestTime":"19:30 EDT","volume":83593,"amount":1492989.1515,"timestamp":1790983807967,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0,"floatShares":3092000000,"shares":3182533200,"eps":-0.31842,"marketStatus":"Market Closed","change":0,"latestTime":"10-02 16:00:00 EDT","open":17.85,"high":17.89,"low":17.78,"amount":38050104.694914,"amplitude":0.006159,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.31842,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0.5,"listingDate":1545627600000,"exchange":"NYSE","adjPreClose":17.86,"dividendRate":0.036456,"preHourTrading":{"tag":"盘前","latestPrice":17.8,"preClose":17.86,"latestTime":"07:47 EDT","volume":1101,"amount":19881.461639999998,"timestamp":1790941627043,"change":-0.06,"changeRate":-0.003359,"amplitude":0.023063},"postHourTrading":{"tag":"盘后","latestPrice":17.86,"preClose":17.86,"latestTime":"19:30 EDT","volume":83593,"amount":1492989.1515,"timestamp":1790983807967,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9096876230657314,"impliedVol":0.1897,"impliedVolPercentile":0.1514},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","floatShares":3092000000,"roa":"2.69%","roe":"-2.26%","lyrEps":-0.304241,"volumeRatio":0.9096876230657314,"shares":3182533200,"dividePrice":0.6336,"high":17.89,"amplitude":0.006159,"preClose":17.86,"low":17.78,"week52Low":12.99,"pbRate":"1.19","psRate":"1.94","week52High":19.1,"institutionHeld":0.1321,"latestPrice":17.86,"eps":-0.31842,"divideRate":0.035476,"volume":2132769,"delay":0,"ttmEps":-0.31842,"open":17.85,"prevYearClose":15.59,"prevWeekClose":18.86,"prevMonthClose":18.19,"prevQuarterClose":18.19,"fiveDayClose":18.86,"twentyDayClose":18.71,"sixtyDayClose":16.61,"earningDate":1793203200000,"earningTime":"盘前"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TAK\",params:#limit:5,,,undefined,":[{"date":"2026-10-29","symbol":"TAK","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2026/09","expectedEps":null,"defaultRemindTime":1793260800000,"name":null,"time":"Pre-MKt","dateTimestamp":1793246400000,"actualEps":null},{"market":"US","date":"2026-07-30","symbol":"TAK","fiscalQuarterEnding":"2026/06","expectedEps":0.41,"name":null,"time":"","type":"earning","dateTimestamp":1785384000000,"reportTimeType":"","actualEps":0.48},{"market":"US","date":"2026-05-13","symbol":"TAK","fiscalQuarterEnding":"2026/03","expectedEps":0.21,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":0.28},{"market":"US","date":"2026-01-29","symbol":"TAK","fiscalQuarterEnding":"2025/12","expectedEps":0.55,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1769662800000,"reportTimeType":"pre","actualEps":0.48},{"date":"2025-10-30","symbol":"TAK","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":0.44,"defaultRemindTime":1761811200000,"name":null,"time":"Pre-MKt","dateTimestamp":1761796800000,"actualEps":0.44}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TAK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TAK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1689307200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TAK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TAK","date":"2026-10-01","current":-56.089442,"percent":0.03125,"low":-61.265492,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"high":247.195474,"avg":38.410771,"sd":49.429032,"marketCap":58103955282.16},"quantilePoints":[{"date":"2021-10-08","current":11.666926,"twenty":23.93319,"median":36.601121,"eighty":89.748252,"marketCap":44862900501.13},{"date":"2021-10-15","current":11.787279,"twenty":23.7033,"median":36.578836,"eighty":89.499696,"marketCap":44516597060.99},{"date":"2021-10-22","current":11.681514,"twenty":23.539863,"median":36.5454,"eighty":88.968468,"marketCap":44293684279.19},{"date":"2021-10-29","current":10.648321,"twenty":23.423498,"median":36.488155,"eighty":88.710165,"marketCap":44164269191.12},{"date":"2021-11-05","current":10.784625,"twenty":23.226892,"median":36.468627,"eighty":88.627312,"marketCap":44983557825.66},{"date":"2021-11-12","current":10.950849,"twenty":22.951173,"median":36.398869,"eighty":88.490851,"marketCap":45493195113.2},{"date":"2021-11-19","current":10.728109,"twenty":22.593579,"median":36.365388,"eighty":88.33002,"marketCap":44596449686.83},{"date":"2021-11-26","current":10.425581,"twenty":22.055183,"median":36.25968,"eighty":88.252042,"marketCap":43512424769.26},{"date":"2021-12-03","current":10.106651,"twenty":21.515452,"median":36.172679,"eighty":88.178937,"marketCap":42286529642.36},{"date":"2021-12-10","current":10.142864,"twenty":21.321368,"median":36.088488,"eighty":87.847529,"marketCap":42348534488.31},{"date":"2021-12-17","current":10.34424,"twenty":21.015505,"median":36.02197,"eighty":87.423521,"marketCap":43082485607.36},{"date":"2021-12-23","current":10.363994,"twenty":20.795645,"median":35.82744,"eighty":87.174965,"marketCap":42874132957.12},{"date":"2021-12-31","current":10.327779,"twenty":20.657578,"median":35.632629,"eighty":86.517022,"marketCap":42437110052.52},{"date":"2022-01-07","current":10.522022,"twenty":20.640925,"median":35.562823,"eighty":86.434171,"marketCap":43033429977.32},{"date":"2022-01-14","current":11.009273,"twenty":20.536864,"median":35.556871,"eighty":86.322076,"marketCap":45750368973.66},{"date":"2022-01-21","current":10.940136,"twenty":20.171308,"median":35.520843,"eighty":86.263593,"marketCap":45488233052.08},{"date":"2022-01-28","current":10.953305,"twenty":19.949589,"median":35.455688,"eighty":85.922437,"marketCap":44994125510.56},{"date":"2022-02-04","current":12.019761,"twenty":19.86233,"median":35.393845,"eighty":85.355005,"marketCap":45736794370.02},{"date":"2022-02-11","current":12.502153,"twenty":19.831282,"median":35.308236,"eighty":85.302091,"marketCap":47298200126.65},{"date":"2022-02-18","current":12.558981,"twenty":19.671006,"median":35.308236,"eighty":85.302091,"marketCap":47834673171.52},{"date":"2022-02-25","current":12.196703,"twenty":19.550551,"median":35.308236,"eighty":85.302091,"marketCap":46263555485.74},{"date":"2022-03-04","current":12.289048,"twenty":19.380891,"median":35.308236,"eighty":85.302091,"marketCap":46976698663.99},{"date":"2022-03-11","current":12.043978,"twenty":19.117196,"median":35.308236,"eighty":85.302091,"marketCap":45095629553.81},{"date":"2022-03-18","current":12.707196,"twenty":18.980245,"median":35.308236,"eighty":85.302091,"marketCap":46769031069.82},{"date":"2022-03-25","current":12.770838,"twenty":18.858799,"median":35.308236,"eighty":85.302091,"marketCap":45895036970.15},{"date":"2022-04-01","current":12.530413,"twenty":18.69121,"median":35.308236,"eighty":85.302091,"marketCap":44742437445.66},{"date":"2022-04-08","current":13.064299,"twenty":18.623126,"median":35.308236,"eighty":85.302091,"marketCap":46073289723.14},{"date":"2022-04-14","current":13.294114,"twenty":18.443795,"median":35.308236,"eighty":85.302091,"marketCap":46294767383.12},{"date":"2022-04-22","current":13.21633,"twenty":18.221438,"median":35.308236,"eighty":85.302091,"marketCap":45025239824.55},{"date":"2022-04-29","current":13.325935,"twenty":17.979017,"median":35.308236,"eighty":85.302091,"marketCap":45022632781.95},{"date":"2022-05-06","current":13.53454,"twenty":17.700642,"median":35.308236,"eighty":85.302091,"marketCap":45566277364},{"date":"2022-05-13","current":24.629857,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":43848144051.53},{"date":"2022-05-20","current":25.018997,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45016426783.75},{"date":"2022-05-27","current":25.119636,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45470626890.48},{"date":"2022-06-03","current":24.280973,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":42728413394.89},{"date":"2022-06-10","current":24.368194,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":41777808638.38},{"date":"2022-06-17","current":23.83145,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":40560767412.66},{"date":"2022-06-24","current":24.871564,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42352646298.73},{"date":"2022-07-01","current":25.220478,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42911856821.29},{"date":"2022-07-08","current":26.059148,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44046297256.04},{"date":"2022-07-15","current":26.763631,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44459950529.79},{"date":"2022-07-22","current":26.817305,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45321441244.41},{"date":"2022-07-29","current":30.743571,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45477961048.28},{"date":"2022-08-05","current":29.247514,"twenty":15.868566,"median":35.251678,"eighty":85.31532,"marketCap":42639852719.36},{"date":"2022-08-12","current":29.748811,"twenty":15.868566,"median":35.071486,"eighty":85.31532,"marketCap":43951767417.68},{"date":"2022-08-19","current":29.8898,"twenty":15.868566,"median":34.741035,"eighty":85.31532,"marketCap":43038704613},{"date":"2022-08-26","current":29.874135,"twenty":15.868566,"median":33.797644,"eighty":85.31532,"marketCap":42969756201.7},{"date":"2022-09-02","current":30.022957,"twenty":15.868566,"median":32.525364,"eighty":85.31532,"marketCap":42304023842.38},{"date":"2022-09-09","current":30.65741,"twenty":15.868566,"median":32.307982,"eighty":85.31532,"marketCap":42457872052.31},{"date":"2022-09-16","current":30.406762,"twenty":15.868566,"median":32.13589,"eighty":85.31532,"marketCap":41975860478.2},{"date":"2022-09-23","current":29.784868,"twenty":15.868566,"median":32.082779,"eighty":85.31532,"marketCap":41053322910.74},{"date":"2022-09-30","current":29.611929,"twenty":15.868566,"median":31.991351,"eighty":85.31532,"marketCap":40398024705.55},{"date":"2022-10-07","current":29.784868,"twenty":15.868566,"median":31.910861,"eighty":85.31532,"marketCap":40490115913.28},{"date":"2022-10-14","current":30.091442,"twenty":15.868566,"median":31.822929,"eighty":85.31532,"marketCap":40007811364.69},{"date":"2022-10-21","current":29.234607,"twenty":15.868566,"median":31.680102,"eighty":85.31532,"marketCap":38943108088.84},{"date":"2022-10-28","current":27.96678,"twenty":15.868566,"median":31.562866,"eighty":85.31532,"marketCap":40412932074.34},{"date":"2022-11-04","current":27.990228,"twenty":15.868566,"median":31.51076,"eighty":85.31532,"marketCap":40544936411.09},{"date":"2022-11-11","current":28.209015,"twenty":15.868566,"median":31.374814,"eighty":85.31532,"marketCap":43206259311.05},{"date":"2022-11-18","current":28.704934,"twenty":15.868566,"median":31.254645,"eighty":85.31532,"marketCap":43730486647.27},{"date":"2022-11-25","current":29.426933,"twenty":15.868566,"median":31.201154,"eighty":85.31532,"marketCap":45057111010.77},{"date":"2022-12-02","current":28.931014,"twenty":15.868566,"median":31.037761,"eighty":85.31532,"marketCap":45570767384.44},{"date":"2022-12-09","current":29.835336,"twenty":15.868566,"median":30.937343,"eighty":85.31532,"marketCap":46637499358.3},{"date":"2022-12-16","current":30.331255,"twenty":15.868566,"median":30.871973,"eighty":85.31532,"marketCap":47313819017.43},{"date":"2022-12-23","current":29.900973,"twenty":15.868566,"median":30.772934,"eighty":85.31532,"marketCap":47996239753.01},{"date":"2022-12-30","current":29.981195,"twenty":15.868566,"median":30.71556,"eighty":85.31532,"marketCap":48463304453.77},{"date":"2023-01-06","current":29.755114,"twenty":15.868566,"median":30.572454,"eighty":85.31532,"marketCap":47870974965.36},{"date":"2023-01-13","current":29.864508,"twenty":15.868566,"median":30.484406,"eighty":85.31532,"marketCap":49882681588.13},{"date":"2023-01-20","current":30.426063,"twenty":15.868566,"median":30.426063,"eighty":85.31532,"marketCap":49943652563.58},{"date":"2023-01-27","current":30.148932,"twenty":15.868566,"median":30.406762,"eighty":85.31532,"marketCap":49467797966.47},{"date":"2023-02-03","current":23.618692,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49524315647.28},{"date":"2023-02-10","current":23.884908,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49885153889.85},{"date":"2023-02-17","current":23.681054,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48373362782.36},{"date":"2023-02-24","current":23.799969,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":47942402215.74},{"date":"2023-03-03","current":24.043461,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48450666632.88},{"date":"2023-03-10","current":24.621048,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50074775527.78},{"date":"2023-03-17","current":24.802252,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51520828536.51},{"date":"2023-03-24","current":24.139732,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50698940566.02},{"date":"2023-03-31","current":24.63238,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":50868882296.85},{"date":"2023-04-06","current":24.898523,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":51908951328.51},{"date":"2023-04-14","current":25.289243,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52430478946.56},{"date":"2023-04-21","current":25.436471,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52090554629.18},{"date":"2023-04-28","current":25.549723,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52360758781.69},{"date":"2023-05-05","current":25.934781,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":53114594501.1},{"date":"2023-05-12","current":21.816188,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51463307525.88},{"date":"2023-05-19","current":21.919152,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50148262100.11},{"date":"2023-05-26","current":22.174322,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50264110513.18},{"date":"2023-06-02","current":21.909524,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50016322403.86},{"date":"2023-06-09","current":22.247876,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50740318667.02},{"date":"2023-06-16","current":22.419504,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50575421543.16},{"date":"2023-06-23","current":22.547244,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":50034367985.85},{"date":"2023-06-30","current":22.199081,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48652831553.96},{"date":"2023-07-07","current":21.625347,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47542321682.04},{"date":"2023-07-14","current":21.105555,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48436114801.39},{"date":"2023-07-21","current":21.512562,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48597606707.51},{"date":"2023-07-28","current":22.302484,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47655983749.28},{"date":"2023-08-04","current":22.405905,"twenty":15.864404,"median":30.349157,"eighty":85.328548,"marketCap":47472091400.73},{"date":"2023-08-11","current":22.962958,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47925971293.26},{"date":"2023-08-18","current":22.653484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":46744998549.67},{"date":"2023-08-25","current":22.947484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47472892956.93},{"date":"2023-09-01","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":48142626644.03},{"date":"2023-09-08","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":47619131084.19},{"date":"2023-09-15","current":25.06738,"twenty":15.864404,"median":30.239629,"eighty":85.328548,"marketCap":51339735089.9},{"date":"2023-09-22","current":24.298853,"twenty":15.864404,"median":30.152523,"eighty":85.328548,"marketCap":49671905160.78},{"date":"2023-09-29","current":23.9378,"twenty":15.864404,"median":30.101284,"eighty":85.328548,"marketCap":48306094881.06},{"date":"2023-10-06","current":23.12801,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":46912236069.61},{"date":"2023-10-13","current":23.4478,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":47185225879.19},{"date":"2023-10-20","current":22.447168,"twenty":15.864404,"median":30.035164,"eighty":85.328548,"marketCap":45133632614.81},{"date":"2023-10-27","current":33.018744,"twenty":15.848805,"median":30.061417,"eighty":85.468491,"marketCap":42045438777.36},{"date":"2023-11-03","current":33.977052,"twenty":15.848805,"median":30.109117,"eighty":85.468491,"marketCap":43262280273.82},{"date":"2023-11-10","current":34.001614,"twenty":15.848805,"median":30.156114,"eighty":85.468491,"marketCap":43146195810.29},{"date":"2023-11-17","current":34.509223,"twenty":15.848805,"median":30.265619,"eighty":85.468491,"marketCap":43924997173.45},{"date":"2023-11-24","current":34.411351,"twenty":15.848805,"median":30.338548,"eighty":85.468491,"marketCap":44071202551.42},{"date":"2023-12-01","current":34.149357,"twenty":15.848805,"median":30.406762,"eighty":85.468491,"marketCap":44271809028.5},{"date":"2023-12-08","current":33.224188,"twenty":15.856081,"median":30.46982,"eighty":85.355005,"marketCap":44164475676.92},{"date":"2023-12-15","current":32.708387,"twenty":15.856081,"median":30.676992,"eighty":85.355005,"marketCap":44261463171.18},{"date":"2023-12-22","current":32.732997,"twenty":15.856081,"median":31.207345,"eighty":85.355005,"marketCap":44132705649.12},{"date":"2023-12-29","current":33.191488,"twenty":15.848805,"median":31.270394,"eighty":85.468491,"marketCap":45078827041.22},{"date":"2024-01-05","current":35.107326,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46553386498.52},{"date":"2024-01-12","current":35.467569,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46529118760.4},{"date":"2024-01-19","current":35.574004,"twenty":15.834252,"median":31.485125,"eighty":85.695464,"marketCap":46054562134.98},{"date":"2024-01-26","current":35.287452,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45813893702.51},{"date":"2024-02-02","current":37.669312,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45919514328.61},{"date":"2024-02-09","current":37.493246,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":44733412617.38},{"date":"2024-02-16","current":38.84015,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46075141205.13},{"date":"2024-02-23","current":39.033823,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46211688108.13},{"date":"2024-03-01","current":38.637675,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45954550562.52},{"date":"2024-03-08","current":38.311953,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":46140815426.08},{"date":"2024-03-15","current":37.871788,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45561442683.96},{"date":"2024-03-22","current":38.796134,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45585981704.56},{"date":"2024-03-28","current":37.000261,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":43584427473.65},{"date":"2024-04-05","current":36.269795,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42616375994.67},{"date":"2024-04-12","current":36.498683,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42430179712.64},{"date":"2024-04-19","current":35.820825,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41294416133.79},{"date":"2024-04-26","current":35.997119,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41249770241.05},{"date":"2024-05-03","current":36.314041,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42076379836.26},{"date":"2024-05-10","current":36.349255,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41627594417.07},{"date":"2024-05-17","current":44.976968,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41733682877.63},{"date":"2024-05-24","current":45.020529,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41285104836.56},{"date":"2024-05-31","current":45.445251,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41644103120.04},{"date":"2024-06-07","current":46.087779,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42404430023},{"date":"2024-06-14","current":45.107651,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41300590483.72},{"date":"2024-06-21","current":43.866156,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":39610552206.76},{"date":"2024-06-28","current":45.436656,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":40691773038.88},{"date":"2024-07-05","current":46.209907,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41429859502.63},{"date":"2024-07-12","current":47.281654,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":43144411716.7},{"date":"2024-07-19","current":46.533596,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42599959119.02},{"date":"2024-07-26","current":46.698609,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":43774096625.98},{"date":"2024-08-02","current":44.272889,"twenty":15.841528,"median":31.485125,"eighty":84.95809,"marketCap":45300242074.37},{"date":"2024-08-09","current":43.014896,"twenty":15.841528,"median":31.485125,"eighty":84.034079,"marketCap":44025677518.59},{"date":"2024-08-16","current":45.710595,"twenty":15.841528,"median":31.485125,"eighty":83.611233,"marketCap":46246726032.37},{"date":"2024-08-23","current":46.418876,"twenty":15.841528,"median":31.485125,"eighty":83.285679,"marketCap":48080793858.92},{"date":"2024-08-30","current":45.805737,"twenty":15.841528,"median":31.485125,"eighty":82.840382,"marketCap":47110126928.06},{"date":"2024-09-06","current":45.150312,"twenty":15.841528,"median":31.485125,"eighty":82.567216,"marketCap":47633333133.33},{"date":"2024-09-13","current":43.733749,"twenty":15.841528,"median":31.485125,"eighty":82.35018,"marketCap":46692187320.02},{"date":"2024-09-20","current":45.192598,"twenty":15.841528,"median":31.485125,"eighty":81.917164,"marketCap":46914983400.73},{"date":"2024-09-27","current":44.008604,"twenty":15.841528,"median":31.485125,"eighty":81.717782,"marketCap":46173769906.47},{"date":"2024-10-04","current":44.8226,"twenty":15.841528,"median":31.485125,"eighty":81.193902,"marketCap":45207064894.75},{"date":"2024-10-11","current":45.034027,"twenty":15.841528,"median":31.485125,"eighty":80.903118,"marketCap":45273197191.14},{"date":"2024-10-18","current":45.203169,"twenty":15.841528,"median":31.485125,"eighty":80.121066,"marketCap":45314702691.87},{"date":"2024-10-25","current":43.395465,"twenty":15.841528,"median":31.485125,"eighty":79.259288,"marketCap":42802477236.79},{"date":"2024-11-01","current":23.34074,"twenty":15.841528,"median":31.394177,"eighty":76.252009,"marketCap":44255337707.7},{"date":"2024-11-08","current":23.061963,"twenty":15.841528,"median":31.223737,"eighty":52.659045,"marketCap":43818726338.15},{"date":"2024-11-15","current":23.302476,"twenty":15.841528,"median":30.720073,"eighty":52.113395,"marketCap":43649113935.95},{"date":"2024-11-22","current":22.482544,"twenty":15.841528,"median":30.492581,"eighty":51.914978,"marketCap":42094765685.01},{"date":"2024-11-29","current":22.318557,"twenty":15.841528,"median":30.428162,"eighty":51.719171,"marketCap":43004121919.03},{"date":"2024-12-06","current":22.537206,"twenty":15.841528,"median":30.363743,"eighty":51.54686,"marketCap":43593417925.5},{"date":"2024-12-13","current":22.602801,"twenty":15.841528,"median":30.265696,"eighty":51.06387,"marketCap":42654808427.14},{"date":"2024-12-20","current":22.438814,"twenty":15.841528,"median":30.156169,"eighty":50.729692,"marketCap":41620825476.96},{"date":"2024-12-27","current":22.89251,"twenty":15.841528,"median":30.11976,"eighty":50.270198,"marketCap":42157933916.75},{"date":"2025-01-03","current":22.854246,"twenty":15.841528,"median":30.084614,"eighty":49.695831,"marketCap":42120101324.52},{"date":"2025-01-10","current":22.526274,"twenty":15.834252,"median":30.039538,"eighty":48.706353,"marketCap":41387819255.78},{"date":"2025-01-17","current":22.072578,"twenty":15.834252,"median":29.98139,"eighty":47.742982,"marketCap":40954868347.09},{"date":"2025-01-24","current":22.056179,"twenty":15.834252,"median":29.928964,"eighty":47.376261,"marketCap":41086375616.12},{"date":"2025-01-31","current":32.066996,"twenty":15.834252,"median":29.8898,"eighty":47.184847,"marketCap":43068627249.87},{"date":"2025-02-07","current":31.518451,"twenty":15.834252,"median":29.8898,"eighty":46.698609,"marketCap":43370831342.3},{"date":"2025-02-14","current":31.625402,"twenty":15.834252,"median":29.8898,"eighty":46.623803,"marketCap":43271885610.15},{"date":"2025-02-21","current":32.135858,"twenty":15.834252,"median":29.8898,"eighty":46.463276,"marketCap":44737299221.36},{"date":"2025-02-28","current":33.019632,"twenty":15.834252,"median":29.8898,"eighty":46.1861,"marketCap":45710719655.87},{"date":"2025-03-07","current":33.965435,"twenty":15.826975,"median":29.881968,"eighty":45.994515,"marketCap":47968574450.17},{"date":"2025-03-14","current":32.579894,"twenty":15.826975,"median":29.881968,"eighty":45.856479,"marketCap":45709305301.84},{"date":"2025-03-21","current":33.462021,"twenty":15.826975,"median":29.881968,"eighty":45.756962,"marketCap":46697220950.86},{"date":"2025-03-28","current":32.837181,"twenty":15.826975,"median":29.881968,"eighty":45.646342,"marketCap":45537525126.69},{"date":"2025-04-04","current":32.910692,"twenty":15.826975,"median":29.881968,"eighty":45.486482,"marketCap":46959977925.4},{"date":"2025-04-11","current":28.911716,"twenty":15.834252,"median":29.864508,"eighty":45.423604,"marketCap":41903036554.51},{"date":"2025-04-17","current":30.516053,"twenty":15.834252,"median":29.864508,"eighty":45.37687,"marketCap":44665727413.14},{"date":"2025-04-25","current":31.299454,"twenty":15.826975,"median":29.853656,"eighty":45.205165,"marketCap":45236702475.67},{"date":"2025-05-02","current":32.353752,"twenty":15.826975,"median":29.853656,"eighty":45.143969,"marketCap":46627023849.03},{"date":"2025-05-09","current":62.186826,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46246122430},{"date":"2025-05-16","current":59.013194,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":43629573670.78},{"date":"2025-05-23","current":60.272181,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":45243750600.82},{"date":"2025-05-30","current":62.428377,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46713186360.41},{"date":"2025-06-06","current":62.153426,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46690667816.43},{"date":"2025-06-13","current":62.934861,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":47259274399.65},{"date":"2025-06-20","current":62.052124,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45950911927.98},{"date":"2025-06-27","current":63.18087,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47191840400.65},{"date":"2025-07-03","current":64.005724,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47693415916.83},{"date":"2025-07-11","current":64.055104,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47209686047.66},{"date":"2025-07-18","current":63.513752,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46158538139.51},{"date":"2025-07-25","current":63.308916,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46555456308.17},{"date":"2025-08-01","current":48.106805,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43759985637.51},{"date":"2025-08-08","current":48.654381,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45191185373.67},{"date":"2025-08-15","current":50.297108,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46622420863.67},{"date":"2025-08-22","current":52.350517,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":48379407617.45},{"date":"2025-08-29","current":50.434002,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46969989485.26},{"date":"2025-09-05","current":52.179399,"twenty":15.818034,"median":29.83907,"eighty":45.065741,"marketCap":48057469940.35},{"date":"2025-09-12","current":51.255365,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47683369897.6},{"date":"2025-09-19","current":51.084248,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47282912126.15},{"date":"2025-09-26","current":50.627935,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46290416349.68},{"date":"2025-10-03","current":48.574526,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45123442627.46},{"date":"2025-10-10","current":48.163844,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43057554125.18},{"date":"2025-10-17","current":47.810202,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43420086875.26},{"date":"2025-10-24","current":49.008023,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43939898848.11},{"date":"2025-10-31","current":196.128812,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":42096877735.37},{"date":"2025-11-07","current":199.628241,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":43122516182.74},{"date":"2025-11-14","current":212.188582,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45471927947.27},{"date":"2025-11-21","current":211.902035,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":44500274886.11},{"date":"2025-11-28","current":215.197333,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45545101317.81},{"date":"2025-12-05","current":210.61257,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45011991214.34},{"date":"2025-12-12","current":212.427372,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45254225772.44},{"date":"2025-12-19","current":219.877613,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":46788038894.3},{"date":"2025-12-26","current":232.581228,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":49307900125.5},{"date":"2026-01-02","current":230.9097,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":48729268900.59},{"date":"2026-01-09","current":242.610705,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":51132650268.4},{"date":"2026-01-16","current":242.276399,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":50569808771.94},{"date":"2026-01-23","current":244.329994,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":51041613744.96},{"date":"2026-01-30","current":73.324517,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":54139767928.12},{"date":"2026-02-06","current":77.171186,"twenty":15.819699,"median":29.842804,"eighty":45.118598,"marketCap":55518181293.68},{"date":"2026-02-13","current":78.528012,"twenty":15.819699,"median":29.842804,"eighty":45.203169,"marketCap":58174278066.56},{"date":"2026-02-20","current":80.98988,"twenty":15.819699,"median":29.842804,"eighty":45.358128,"marketCap":59032990935.72},{"date":"2026-02-27","current":81.400335,"twenty":15.819699,"median":29.842804,"eighty":45.393454,"marketCap":58849002644.08},{"date":"2026-03-06","current":79.553824,"twenty":15.819699,"median":29.842804,"eighty":45.478025,"marketCap":56940998250.88},{"date":"2026-03-13","current":79.357982,"twenty":15.819699,"median":29.842804,"eighty":45.710595,"marketCap":56281429903.04},{"date":"2026-03-20","current":80.68691,"twenty":15.819699,"median":29.842804,"eighty":45.805737,"marketCap":57640580474.28},{"date":"2026-03-27","current":81.700474,"twenty":15.819699,"median":29.842804,"eighty":45.946205,"marketCap":57787054549.19},{"date":"2026-04-02","current":82.399965,"twenty":15.819699,"median":29.842804,"eighty":46.155453,"marketCap":58414619614.42},{"date":"2026-04-10","current":80.189575,"twenty":15.819699,"median":29.842804,"eighty":46.418876,"marketCap":56894786236.46},{"date":"2026-04-17","current":78.147063,"twenty":15.819699,"median":29.842804,"eighty":46.632604,"marketCap":55443526794.1},{"date":"2026-04-24","current":74.636784,"twenty":15.819699,"median":29.842804,"eighty":46.753613,"marketCap":52882297496.5},{"date":"2026-05-01","current":73.293741,"twenty":15.819699,"median":29.842804,"eighty":47.281654,"marketCap":52807070808.15},{"date":"2026-05-08","current":72.930001,"twenty":15.819699,"median":29.842804,"eighty":47.890056,"marketCap":52641729349.45},{"date":"2026-05-15","current":43.474739,"twenty":21.105555,"median":29.8898,"eighty":48.072582,"marketCap":52716863079.61},{"date":"2026-05-22","current":42.090665,"twenty":21.242858,"median":29.981195,"eighty":48.072582,"marketCap":50702234820.63},{"date":"2026-05-29","current":42.164812,"twenty":21.619498,"median":30.013965,"eighty":48.079427,"marketCap":50785809331.9},{"date":"2026-06-05","current":40.583014,"twenty":21.679053,"median":30.061417,"eighty":48.072582,"marketCap":48640465321.16},{"date":"2026-06-12","current":41.868225,"twenty":21.919152,"median":30.109117,"eighty":48.072582,"marketCap":50028878946.35},{"date":"2026-06-18","current":41.497491,"twenty":22.002933,"median":30.148932,"eighty":48.072582,"marketCap":49432180569.37},{"date":"2026-06-26","current":-52.738505,"twenty":22.014366,"median":30.152523,"eighty":48.079427,"marketCap":49718648879.09},{"date":"2026-07-02","current":-54.677192,"twenty":22.014366,"median":30.152523,"eighty":48.079427,"marketCap":51786280766.08},{"date":"2026-07-10","current":-55.558413,"twenty":22.014366,"median":30.152523,"eighty":48.079427,"marketCap":52145787737.79},{"date":"2026-07-17","current":-56.812857,"twenty":22.014366,"median":30.152523,"eighty":48.079427,"marketCap":53292981615.83},{"date":"2026-07-24","current":-59.180349,"twenty":22.014366,"median":30.152523,"eighty":48.079427,"marketCap":55033430509.43},{"date":"2026-07-31","current":-53.86164,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":55207403658.2},{"date":"2026-08-07","current":-54.125428,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":55841298206.35},{"date":"2026-08-14","current":-54.819093,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":56217337436.1},{"date":"2026-08-21","current":-56.313893,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":57973616102.57},{"date":"2026-08-28","current":-56.66561,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":58133933551.36},{"date":"2026-09-04","current":-56.206423,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":59042664944.99},{"date":"2026-09-11","current":-55.356439,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":58736837078.32},{"date":"2026-09-18","current":-58.306959,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":61160748054.37},{"date":"2026-09-25","current":-58.316729,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":59951647155.23},{"date":"2026-10-01","current":-55.991485,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":58103955282.16}],"updateTime":1790987708936},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TAK\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651915711","title":"Takeda, Indonesian Government Launch Program to Build National Plasma Ecosystem","url":"https://stock-news.laohu8.com/highlight/detail?id=2651915711","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651915711?lang=en_us&edition=fundamental","pubTime":"2026-07-13 15:45","pubTimestamp":1783928738,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  has teamed up with the Indonesian government to build the country's plasma ecosystem and expand access to plasma-derived therapies, the company said over the weekend.Under the deal, the company secured a plasma fractionation license from the country's Ministry of Health and will invest up to $30 million in a two-year pilot program to open plasma donation centers as part of a multi-year plan to develop large-scale plasma collection and manufacturing capabilities.The first donation center is expected to open in 2027.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BGSX","NHLD","TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651916902","title":"Takeda, the Indoensian Government announce collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2651916902","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651916902?lang=en_us&edition=fundamental","pubTime":"2026-07-13 07:15","pubTimestamp":1783898106,"startTime":"0","endTime":"0","summary":"Takeda (TAK) and the Indonesian Government announced a collaboration aimed at strengthening Indonesia’s plasma ecosystem and supporting equitable a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-the-indoensian-government-announce-collaboration-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-the-indoensian-government-announce-collaboration-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126358006","title":"Insilico Medicine Announces Strategic Collaboration with Takeda for AI-Driven Drug Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=1126358006","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126358006?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:50","pubTimestamp":1782953422,"startTime":"0","endTime":"0","summary":"Insilico Medicine (03696) has announced that the company has entered into a strategic collaboration agreement with Takeda Pharmaceutical Co Ltd (TAK).The partnership will leverage Insilico's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAK","03696","BK1141","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648152293","title":"Takeda, Insilico Strike AI Drug-discovery Deal Worth up to $600.0 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2648152293","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648152293?lang=en_us&edition=fundamental","pubTime":"2026-07-02 07:30","pubTimestamp":1782948600,"startTime":"0","endTime":"0","summary":"Japanese pharmaceutical major Takeda is forging an AI drug-discovery partnership with biotech firm InSilico with a potential initial value of $600.0 million, people familiar with the matter say.Accord","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIPO","AGIX","CHAT","BK4007","BK1141","03696","ARTY","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647080113","title":"Alkermes Faces Risk on Orexin-Related Value From Upcoming Updates, BofA Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2647080113","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647080113?lang=en_us&edition=fundamental","pubTime":"2026-06-29 23:14","pubTimestamp":1782746061,"startTime":"0","endTime":"0","summary":"Alkermes  stock has been re-rated following a recent orexin-peer takeout, but upcoming orexin updates risk eroding newly ascribed orexin-related value, BofA Securities said in a research note Monday.ALKS largely trades on data points informing the commercial opportunity for its phase 2 and phase 3 pipeline asset orexin in hypersomnolent disorders, the brokerage said.The firm said possible negative catalysts include Alkermes' phase 2 Vibrance-3 data in idiopathic hypersomnia, reading out late 2026 or early 2027.BofA sees idiopathic hypersomnia as a risky segment in the broader hypersomnia market, as competition from Takeda Pharmaceutical's  phase 2 data for TAK-360 in narcolepsy type 2 and idiopathic hypersomnia could reinforce the narrative that the market is crowded. Key opinion leaders have also flagged lower unmet need for another wake promoter, and BofA sees profit and loss risk as well, according to the note.BofA downgraded Alkermes to underperform from neutral with a price target","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","TAK","BK4007","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152253299","title":"Takeda's First Female CEO Outlines Strategy for Growth Rebound and Major Product Launches","url":"https://stock-news.laohu8.com/highlight/detail?id=1152253299","media":"Stock News","labels":["executive","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152253299?lang=en_us&edition=fundamental","pubTime":"2026-06-25 19:02","pubTimestamp":1782385352,"startTime":"0","endTime":"0","summary":"The new Chief Executive Officer of Takeda Pharmaceutical Co Ltd (TAK.US), Julie Kim, has stated the company aims to return to growth within two to three years as it prepares to launch a series of new...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645984248","title":"Takeda Pharmaceutical Appoints Julie Kim as Chief Executive","url":"https://stock-news.laohu8.com/highlight/detail?id=2645984248","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645984248?lang=en_us&edition=fundamental","pubTime":"2026-06-24 15:53","pubTimestamp":1782287587,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  said Wednesday that it has appointed Julie Kim as president and chief executive officer.Kim succeeds Christophe Weber, who retired from both the company and its board following the annual meeting of shareholders.Kim joined Takeda in 2019 and was named CEO-elect in 2025, the company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645386837","title":"Asian Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2645386837","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645386837?lang=en_us&edition=fundamental","pubTime":"2026-06-23 22:48","pubTimestamp":1782226129,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts fell Tuesday morning, tumbling 3.1% to 2,816.27 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by mobile app developer Cheetah Mobile  and pharmaceutical company Takeda Pharmaceutical , which rose 2% each. They were followed by travel company Tuniu , which was up 0.1%.The decliners from North Asia were led by fintech firm Jiayin Group  and semiconductor company ASE Technology , which fell 29.9% and 7.6% respectively. They were followed by video display maker LG Display  and semiconductor company Silicon Motion Technology , which shed 6.9% and 6.4% respectively.From South Asia, the gainers were led by IT firm Wipro  and telecommunications operator Telekomunikasi Indonesia , which increased 3.1% and 1.5% respectively. They were followed by IT firm Infosys  and pharmaceutical company Dr. Reddy's Laboratories , which advanced 1% each.The decliners from South Asia were lenders ICICI Bank  and HDFC Bank , whi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0630378692.HKD","SIMO","IE00B0JY6M65.USD","BK4526","LU0164881194.USD","IBN","LU2089985449.USD","TOUR","BK4148","LU0390134368.USD","LU0791591158.USD","LU0918141705.HKD","LU0821914370.USD","LU1282648689.USD","INFY","LU1868837565.USD","LU1868838027.USD","JFIN","LU0823039010.USD","LU0197773673.USD","LU0541501648.USD","LU1366334651.USD","LU1805238398.USD","BK4535","SG9999002950.SGD","IE00B3M56506.USD","IE00BYTNYM70.SGD","BK4543","HDB","LU0287143357.SGD","LU1508157978.USD","LU0918141887.USD","LU0868486357.SGD","IE0001KFT4U8.USD","BK4518","LU0197773160.USD","BK4523","LU0261950470.USD","LU0251144936.SGD","BK4141","LU0898667661.SGD","BK4509","LU2008162690.USD","LU1323998911.USD","LU0251143458.SGD","LU0541502299.USD","LU0828237940.HKD","RDY","LU2087589342.USD","LU1105468828.SGD","SG9999014013.SGD","LU1804176565.USD","LPL","LU1791710582.SGD","BK4588","LU1481012133.USD","SG9999014039.USD","ASX","LU1854104046.USD","LU0261947096.USD","LU1102505929.USD","TLK","BK4566","IE00B7N09G41.SGD","LU1366334578.USD","LU0823038988.USD","LU2265009873.SGD","LU0797268264.HKD","LU0264410563.USD","LU0048597586.USD","LU0862451753.SGD","LU2279701549.SGD","TAK","BK4142","LU0274383776.USD","BK4557","LU0333810181.USD","LU0066902890.USD","BK4207","BK4548","LU0231203729.USD","SG9999004220.SGD","LU0708995666.HKD","LU0431992006.USD","BK4532","LU0197229882.USD","LU0630378429.USD","LU1791710400.SGD","LU1102505762.USD","CMCM","LU2226246903.HKD","LU0248272758.USD","LU1048596156.SGD","LU0143863198.USD","LU0181495838.USD","BK4115","LU0531971678.HKD","BK4134","LU0048575426.USD","LU0890818403.SGD","LU2663582299.SGD","LU0536402901.SGD","LU0791590937.USD","LU0456842615.SGD","BK4166","BK4585","LU1854103824.USD","LU1048588211.SGD","WIT","LU0348744763.USD","LU0143863784.USD","BK4596","SG9999014021.USD","LU0348814723.USD","LU0528227936.USD","BK4533","SG9999014005.SGD","LU1868837722.USD","LU0831103253.SGD","BK4007","LU0072462343.USD","BK4023","LU0348816934.USD","LU1267930656.SGD","LU2177674079.SGD","LU0307460401.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645839257","title":"Takeda Canada Says Zasocitinib Shows Superiority to Deucravacitinib in Phase 3 Psoriasis Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2645839257","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645839257?lang=en_us&edition=fundamental","pubTime":"2026-06-23 21:01","pubTimestamp":1782219674,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical's (TAK) Canadian unit, Takeda Canada, said Tuesday that its investigational oral tyrosine kinase 2 inhibitor zasocitinib showed \"statistical superiority\" over deucravacitinib for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645836029","title":"Takeda Canada reports ‘positive’ results from Phase 3 study of zasocitinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2645836029","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645836029?lang=en_us&edition=fundamental","pubTime":"2026-06-23 20:40","pubTimestamp":1782218451,"startTime":"0","endTime":"0","summary":"Takeda (TAK) Canada is pleased to announce positive topline results for the Phase 3, randomized, multicenter, double-blind study comparing zasociti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-canada-reports-positive-results-from-phase-3-study-of-zasocitinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-canada-reports-positive-results-from-phase-3-study-of-zasocitinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644724607","title":"Takeda’s High-Stakes Overhaul: CEO Transition and Major Restructuring Raise Execution and Profitability Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2644724607","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644724607?lang=en_us&edition=fundamental","pubTime":"2026-06-18 14:00","pubTimestamp":1781762411,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company (TAK) has disclosed a new risk, in the Corporate Activity and Growth category. Takeda Pharmaceutical Company faces ex...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-high-stakes-overhaul-ceo-transition-and-major-restructuring-raise-execution-and-profitability-risks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-high-stakes-overhaul-ceo-transition-and-major-restructuring-raise-execution-and-profitability-risks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643207813","title":"Takeda presents additional results from oveporexton studies at SLEEP 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2643207813","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643207813?lang=en_us&edition=fundamental","pubTime":"2026-06-16 00:05","pubTimestamp":1781539552,"startTime":"0","endTime":"0","summary":"Takeda (TAK) presented additional results from two pivotal studies at SLEEP 2026, showing oveporexton, an oral orexin receptor 2-selective agonist,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-presents-additional-results-from-oveporexton-studies-at-sleep-2026-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-presents-additional-results-from-oveporexton-studies-at-sleep-2026-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642281322","title":"Takeda Pharmaceutical's Psoriasis Treatment Beats Competitor in Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2642281322","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642281322?lang=en_us&edition=fundamental","pubTime":"2026-06-11 19:54","pubTimestamp":1781178848,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  said Thursday its experimental psoriasis medication zasocitinib outperformed competing drug deucravacitinib in a phase 3 clinical trial.More than 35% of individuals given the daily oral therapy reached total skin clearance after 16 weeks, more than 2.5 times the response rate for deucravacitinib, the company said.The trial met its primary and secondary endpoints while showing a safety profile consistent with prior research, and the company intends to submit a regulatory approval request within the fiscal year, Takeda said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642896372","title":"Takeda announces results for Phase 3 study of TAK-279","url":"https://stock-news.laohu8.com/highlight/detail?id=2642896372","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642896372?lang=en_us&edition=fundamental","pubTime":"2026-06-11 19:12","pubTimestamp":1781176351,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced positive topline results for the Phase 3, randomized, multicenter, double-blind study comparing zasocitinib, TAK-279, an inv...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-announces-results-for-phase-3-study-of-tak-279-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-announces-results-for-phase-3-study-of-tak-279-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642490543","title":"Takeda's Application for ENTYVIO IV Accepted by FDA in Pediatric Ulcerative Colitis and Crohn's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2642490543","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642490543?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:59","pubTimestamp":1781038794,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  said late Tuesday the US Food and Drug Administration has accepted for review its supplemental biologics license application for intravenous ENTYVIO for the treatment of moderate to severely active ulcerative colitis and Crohn's disease in pediatric patients aged 2 years and older.If approved, ENTYVIO would be the only gut-focused treatment option for these patients, the company said.The FDA has set a Prescription Drug User Fee Act goal date in Q1 2027.Takeda said it has also submitted a marketing authorization application to the European Medicines Agency for ENTYVIO IV to treat pediatric patients aged 2 years and older.ENTYVIO is currently approved for the treatment of moderate to severely active UC and Crohn's disease in adults.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4588","BK4585","TAK","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642977044","title":"FDA accepts Takeda’s application for intravenous Entyvio","url":"https://stock-news.laohu8.com/highlight/detail?id=2642977044","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642977044?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:37","pubTimestamp":1781037420,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced the U.S. Food and Drug Administration has accepted for review its supplemental Biologics License Application for intravenous...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-accepts-takedas-application-for-intravenous-entyvio-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-accepts-takedas-application-for-intravenous-entyvio-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LABU","BK4585","BK4588","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642875491","title":"Takeda’s TAK-360 Narcolepsy Trial Moves Forward, Expanding Its Specialty CNS Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2642875491","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642875491?lang=en_us&edition=fundamental","pubTime":"2026-06-10 00:30","pubTimestamp":1781022647,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda is moving ahead with a phase 2 trial of TAK-360 fo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-tak-360-narcolepsy-trial-moves-forward-expanding-its-specialty-cns-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-tak-360-narcolepsy-trial-moves-forward-expanding-its-specialty-cns-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641111946","title":"Takeda swings to FY25 net loss of JPY 152.1 billion; FY25 revenue falls 1.7% to JPY 4.51 trillion","url":"https://stock-news.laohu8.com/highlight/detail?id=2641111946","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641111946?lang=en_us&edition=fundamental","pubTime":"2026-06-05 17:51","pubTimestamp":1780653060,"startTime":"0","endTime":"0","summary":"Takeda posted FY2025 revenue of JPY 4.51 trillion, down 1.7%, while operating profit dropped 98.2% to JPY 6.2 billion.It turned to a net loss attributable to owners of JPY 152.4 billion; basic EPS was a loss of JPY 96.75.Other operating expenses widened to JPY 559 billion, driven by a JPY 403.5 billion provision tied to the AMITIZA antitrust verdict.It booked an additional legal provision of JPY 402.5 billion with related tax benefits of JPY 58.4 billion; the FY2025 year-end dividend stayed JPY 100.FY2026 forecast was unchanged, targeting revenue of JPY 4.64 trillion with operating profit of JPY 420 billion; dividend guidance remains JPY 204.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Takeda Pharmaceutical Co. Ltd. published the or","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nNDLbb0RFW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641169669","title":"Takeda’s New Mezagitamab Trial Targets High-Risk Kidney Rejection, Bolstering Long-Term Pipeline Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2641169669","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641169669?lang=en_us&edition=fundamental","pubTime":"2026-06-05 00:33","pubTimestamp":1780590839,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) has launched a new Phase 2 trial called “A D...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-new-mezagitamab-trial-targets-high-risk-kidney-rejection-bolstering-long-term-pipeline-story?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-new-mezagitamab-trial-targets-high-risk-kidney-rejection-bolstering-long-term-pipeline-story?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641616965","title":"Takeda’s Real-World Maribavir Study in Argentina: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2641616965","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641616965?lang=en_us&edition=fundamental","pubTime":"2026-06-05 00:33","pubTimestamp":1780590827,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) is running an observational study in Argenti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-real-world-maribavir-study-in-argentina-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-real-world-maribavir-study-in-argentina-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4211","BK4007","ISBC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":88,"code":"91000000","status":"200"}]}}